Celularity Inc. (CELU) vs ImageneBio Inc (IMA)
A side-by-side comparison of Celularity Inc. and ImageneBio Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELU
Celularity Inc.
$1.72HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
IMA
ImageneBio Inc
$4.81HealthcareDelayed quote: Oct 6, 2026, 10:56 AM EDT
Total return — CELU vs IMA
growth of $100 · dividends reinvested · last 6yCELU -98.3% (-49.3%/yr)IMA -98.8% (-52.0%/yr)CELU compounded faster over this window
CELU IMA
CELU vs IMA: by the numbers
- •IMA is the larger company ($54M vs $50M market cap).
- •Both run net losses; CELU's is the smaller (-375.77% vs -5668.62% net margin).
Metrics side by side
Valuation
| Metric | CELU | IMA |
|---|---|---|
| P/S ratio | 2.62 | N/A |
| P/B ratio | N/A | 0.38 |
Profitability
| Metric | CELU | IMA |
|---|---|---|
| Gross margin | 79.62% | -29.12% |
| Operating margin | -230.92% | -6056.37% |
| Net margin | -375.77% | -5668.62% |
| ROE | N/A | -36.94% |
| ROIC | -192.99% | -40.53% |
Growth (annualized)
| Metric | CELU | IMA |
|---|---|---|
| Revenue CAGR (5Y) | 8.31% | N/A |
| Total return CAGR (5Y) | -52.57% | -50.73% |
Frequently asked
- How have CELU and IMA total returns compared?
- Over the past 5 years, CELU delivered -52.57% and IMA delivered -50.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.